Skip to search.
 TSX Up 0.20% TSX Ventures Down 0.39%

More On NRI.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Nuvo Pharmaceuticals Inc. (NRI.TO)

-Toronto
5.56 Up 0.01(0.18%) 3:57PM EST
Prev Close:5.55
Open:5.66
Bid:5.56
Ask:5.60
1y Target Est:N/A
Beta:-0.393214
Earnings Date:Feb 15 - Feb 20 (Est.)
Day's Range:5.55 - 5.66
52wk Range:3.77 - 8.35
Volume:11,985
Avg Vol (3m):19,927
Market Cap:63.96M
P/E (ttm):22.60
EPS (ttm):0.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

Key Statistics

Forward P/E (1 yr):9.27
P/S (ttm):2.13
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :0.50
Quarterly EPS Est (Dec-16) :0.14
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nuvo Research Inc. operates as a life sciences company. The company operates through two segments, Nuvo Pharma and Crescita. It offers Pennsaid, a topical non-steroidal anti-inflammatory drug that is used to treat the signs and symptoms of osteoar... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback